<DOC>
	<DOCNO>NCT02176577</DOCNO>
	<brief_summary>The purpose study evaluate Pharmacokinetics Product 0405 Treatment Atopic Dermatitis Adolescent Subjects .</brief_summary>
	<brief_title>Study Determine Pharmacokinetics Product 0405</brief_title>
	<detailed_description>Treament medication administer topically twice daily 28 day .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Clinical diagnosis Atopic Dermatitis Good health exception Atopic Dermatitis Percent body surface area minimum Subject nursing , pregnant planning pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>